| Literature DB >> 31387916 |
Seungwon Lee1, Hyekang Kim1, Gihoon You1, Young-Min Kim2, Seunghun Lee3, Viet-Hoan Le1, Ohseop Kwon1, Sin-Hyeog Im1,2,4, You-Me Kim1,2, Kwang Soon Kim1,4, Young Chul Sung1,2, Ki Hean Kim1,3, Charles D Surh1,2,4,5, Yunji Park1, Seung-Woo Lee1,2.
Abstract
The microbiota regulate hematopoiesis in the bone marrow (BM); however, the detailed mechanisms remain largely unknown. In this study, we explored how microbiota-derived molecules (MDMs) were transferred to the BM and sensed by the local immune cells to control hematopoiesis under steady-state conditions. We reveal that MDMs, including bacterial DNA (bDNA), reach the BM via systemic blood circulation and are captured by CX3CR1+ mononuclear cells (MNCs). CX3CR1+ MNCs sense MDMs via endolysosomal Toll-like receptors (TLRs) to produce inflammatory cytokines, which control the basal expansion of hematopoietic progenitors, but not hematopoietic stem cells, and their differentiation potential toward myeloid lineages. CX3CR1+ MNCs colocate with hematopoietic progenitors at the perivascular region, and the depletion of CX3CR1+ MNCs impedes bDNA influx into the BM. Moreover, the abrogation of TLR pathways in CX3CR1+ MNCs abolished the microbiota effect on hematopoiesis. These studies demonstrate that systemic MDMs control BM hematopoiesis by producing CX3CR1+ MNC-mediated cytokines in the steady-state.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31387916 PMCID: PMC6888141 DOI: 10.1182/blood.2019000495
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113